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Abstract
Background & objectives: Probability models for assessing a mosquito repellent’s potential to
reduce malaria transmission are not readily available to public health researchers. To provide a
means for estimating the epidemiological efficacy of mosquito repellents in communities, we
developed a simple mathematical model.
Study design: A static probability model is presented to simulate malaria infection in a community
during a single transmission season. The model includes five parameters—sporozoite rate, human
infection rate, biting pressure, repellent efficacy, and product-acceptance rate.
Interventions: The model assumes that a certain percentage of the population uses a personal
mosquito repellent over the course of a seven-month transmission season and that this repellent
maintains a constant rate of protective efficacy against the bites of malaria vectors.
Main outcome measures: This model measures the probability of evading malaria infection under
diverse  circumstances, e.g. vector biting pressure, repellent efficacy, and product acceptance.
Results & conclusion: Absolute protection using mosquito repellents alone requires high rates of
repellent efficacy and product acceptance may vary. Using performance data from a highly effective
repellent, the model estimates an 88.9% reduction of infections over a seven-month transmission
season. A corresponding reduction in the incidence of super-infection in community members not
completely evading infection can also be presumed. Thus, the model shows that mass distribution
of a repellent with >98% efficacy and >98% product acceptance would suppress new malaria
infections to levels lower than those achieved with insecticide treated nets (ITNs). A combination
of both interventions could create synergies that result in reductions of disease burden significantly
greater than with the use of ITNs alone.
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Introduction
Mosquito repellent interventions against vector-borne
diseases are rarely considered in public health
programmes. In fact, if they are considered at all,
they are recommended as supplementary measures
and left to the discretion of the individuals with the
economic means to acquire them. This institutional
tendency to disregard repellents is not supported by
scientific evidence, as few large-scale epidemiologi-
cal studies of the effect of mosquito repellents on
disease transmission have been undertaken. Where
such field studies are lacking, mathematical model-
ing can demonstrate how a repellent-only interven-
tion can influence the suppression of malaria. How-
ever, the theoretical tools for assessing repellent-
based interventions against malaria are similarly lack-
ing. While some models have been used to evaluate J  VECTOR  BORNE  DIS  47, DECEMBER 2010 218
the repellent, irritant, and toxic effects of insecticide
residues on anopheline mosquitoes1, no probability
models are available for assessing the disease reduc-
tion potential of compounds that function solely as
mosquito repellents.
To estimate the epidemiological efficacy of repel-
lents in poor communities, we developed a simple
mathematical model. To illustrate the model, we in-
corporated the performance data of NO MAS (NM),
a low-cost repellent lotion made with para-menthane-
3,8-diol (PMD) and lemongrass oil (LGO). Designed
to reduce infectious disease in conditions of severe
poverty, numerous iterations of this water-based re-
pellent have proved to be superior to deet (N,N-di-
ethyl-3-methylbenzamide) when tested against dis-
ease vectors in efficacy studies, both in the field2
and laboratory (Barnard, personal communication).
Material & Methods
Using a static probability model, we estimated the
mean probability of avoiding malaria infections in
populations protected by NM. Assuming that each
mosquito-biting attempt in a transmission season is
an independent event, the following expression esti-
mates the probability that members of a community,
at risk of vector-borne infections, can escape infec-
tion by using repellent-only interventions:
Fe= (1 – sh)b(1–rc)
Where, Fe = Epidemiological efficacy—the probabil-
ity that a community member avoids infection dur-
ing the time period associated with variable; s =
sporozoite (or vector infection) rate—the propor-
tion of vectors infected and infective; h = human in-
fection rate—the proportion of potentially infective
mosquito bites that result in human infections; b =
biting pressure—the average number of bites per per-
son per unit of time if no repellent was used; r =
repellent efficacy—the proportion of potential mos-
quito bites that are repelled; and c = product accep-
tance rate—the proportion of people using repellent
regularly and appropriately.
In effect, this equation predicts the probability that
the average person in this population exposed to in-
fected vectors will avoid infection. The base prob-
ability of becoming infected by a mosquito bite is
represented as a product of the proportion of mos-
quitoes infected (s) and the probability that a single
infectious bite leads to a human infection (h). Each
mosquito bite is then considered as an independent
event, hence, its representation as an exponential
term. The biting pressure (b) is modified by the re-
pellent efficacy (r) and the proportion of the com-
munity (c) that accepts regular use of a repellent.
Subtracting from the integer one (1) delivers the pro-
portion of host-seeking mosquitoes that evade the
effects of repellent and are able to bite members of
the community to which this estimator model is ap-
plied. Human infection rate (h) per infectious bite
can vary greatly by age and transmission intensity.
The parameter estimate used here (0.022) is derived
from a robust data set originally published by Pull
and Grab3 and further evaluated by Nedelman4. Re-
cent investigations5 indicate that this value provides
a reasonable intermediate estimate of (h) for partially
immune populations living in areas of moderate to
intense malaria transmission.
Alternatively, (h) can be estimated from specific
localities by exploiting the relationship between en-
tomological inoculation rate (Eir) and prevalence.
The proportion of people escaping malaria infection
over a given period (Pn) is a function of their prob-
ability of escaping infection from one infective mos-
quito bite (1–h) iterated over the number of infec-
tive bites (Eir) they receive over a period of the same
length preceding incubation.
Pn = (1–h)1/E
ir
Since, h is the parameter of interest in our estimator,
solving for h yields:
h =  1–Pn1/E
ir
This provides a means of estimating (h) from two
parameters obtained from field-based blood surveys 219 KISZEWSKI & DARLING : REPELLENT AGAINST MALARIA
and entomological assessments. Ideally, (h) should
be estimated separately for distinct age classes (in-
fants <6 months old children >6 months, <5 yr, 5 to
15-yr old, and adults) to account for differences in
protective immunity and then converted into a
weighted average for each community.
Sporozoite rates (s) can also vary over a wide range,
both temporally and spatially. We have chosen an
illustrative value (0.015) to represent situations where
the vector infection rate and malaria transmission are
relatively intense, but not extreme. This value corre-
sponds roughly to median sporozoite rates estimated
from several mesoendemic areas in Ethiopia6,7.
Using the above values as constant, we explored how
diverse levels of user compliance and efficacy could
influence malaria infections under a wide range of
biting pressures. However, to establish the scale of
protection that is possible with this repellent inter-
vention, these values were applied to a large-scale
hypothetical population scenario: a portion of Equa-
torial West Africa where 10 million people are at
high risk of contracting malaria.
Applying the above parameters for vector and hu-
man infection rates, we hypothesized that significant
transmission occurs over a seven-month season, with
a mean biting pressure (for people not protected from
malaria vectors by other measures) of 40 bites per
night. Again, we chose a value representative of many
situations around the world without going to ex-
tremes. This biting pressure corresponds roughly to
the median biting levels measured at nine sites in a
rice-growing region of lowland Kenya8.
Efficacy data for NM from a California field study
(Carroll, personal communication) indicated a >6 h
100% complete protection time (CPT). Numerous
cage tests in Florida (Barnard, personal communica-
tion) have indicated a >9 h 100% CPT. Data from a
120-day product acceptance study in Loreto, Peru
(Kiszewski et al, in preparation) show that 99.5% of
369 NM-using households elected to continue re-
pellent use at the end of the study. We assumed a
repellent efficacy of 98% in our theoretical West
African scenario.
Results
To protect vulnerable populations from malaria infec-
tion during prolonged transmission seasons, it is nec-
essary for mosquito repellents to achieve both high
product acceptance and high efficacy rates. Indeed, the
probability of avoiding infections is highly sensitive to
small changes in these exponential parameters, espe-
cially where biting rates are most intense (Fig. 1).
In the absence of other preventive interventions, and
under the conditions described in the previous sce-
nario (s = 0.015, h = 0.022, b = 40) at least 9,375,000
malaria infections would be expected during a seven-
month malaria transmission season. However, with
mass distribution of a highly effective mosquito re-
pellent (r = 0.98, c = 0.98), only about 1,040,000
malaria infections would be expected in the same
Fig. 1: Probability of avoiding malaria infection. The prob-
ability that a repellent-using population can avoid
malaria infection during a seven-month transmission
season, assuming a sporozoite rate of 1.5% and a
human infection rate of 2.2%. Scenarios of repellent
efficacy and user compliance include: (a) 99.9% effi-
cacy and compliance; (b) 99% efficacy and compli-
ance; (c) 98% efficacy and compliance (correspond-
ing to estimates of compliance in a 2007 Peruvian
field study); (d) 95% efficacy and 80% compliance;
and (e) Zero protection or compliance. J  VECTOR  BORNE  DIS  47, DECEMBER 2010 220
period. This represents an 88.9% reduction in infec-
tions derived solely from the use of an efficacious,
well-tolerated repellent. Substituting lower efficacy
(95%) and product acceptance (80%) still results in
48.2% fewer new infections than the unprotected
population, approaching the burden reductions ex-
pected in communities where at least 80% of people
at risk possess and use ITNs9.
Discussion & Conclusion
The estimator calculates the probability of avoiding
all infective bites. It does not distinguish between
single, serial or multiple infections among those not
escaping infection. It also disregards the diversion
of infective bites toward unprotected people, an event
that could increase the likelihood of infection among
them, especially in areas where vectors are highly
focused on human biting. However, where product
acceptance rates reach levels observed in the Peru-
vian study (>98%), the epidemiological significance
of diversion becomes negligible.
The output generated in Fig. 1 depicts the probabil-
ity of completely avoiding a patent infection of
falciparum malaria. Absolute prevention is particularly
critical for vulnerable subpopulations, such as preg-
nant women and children <5 yr old, where every clini-
cal infection has the potential to cause severe illness
or death. However, not depicted explicitly in our simple
model is the effect of reduced exposure to infectious
bites on the clonal diversity and multiplicity of infec-
tions. Fewer and less diverse super-infections would
be expected in communities using repellents. Certain
studies suggest that reduced super-infection can lead
to more favorable outcomes in people afflicted with
malaria10,11, although in some cases, protective im-
munity may also be affected. Thus, repellents may
benefit not only those who completely evade trans-
mission but also those who reduce their overall inci-
dence of infection across a transmission season.
This model was conceived during a time of extraor-
dinary disruptions in the world’s economy and cli-
mate. It is a time when funding for clinical studies to
measure the impact of repellents on malaria is scarce,
and finding dependable weather conditions to stage
such costly studies is less certain. In these circum-
stances, the model could provide public health re-
searchers in malaria endemic countries with a low-
cost means to estimate the epidemiological impact
of repellents in their communities. Importantly, this
“snapshot” of parasitaemic conditions is one that
could be employed without significant moneys from
donors, or technical assistance from abroad. While it
is clearly not intended to replace full clinical studies,
the estimator could help demonstrate the need for
such further studies and the desirability of funding
them in future. It can also be used to determine the
range of impacts possible across a range of likely
parameters.
Our model suggests that a highly efficacious repel-
lent, one that is also acceptable to users, could sur-
pass the disease reduction potential of ITNs when dis-
tributed en masse. When deployed together with
ITNs, such repellents could offer powerful synergies,
compensating for incomplete coverage by bed nets,
while enhancing their mass killing effects by repelling
mosquitoes toward the net’s treated surfaces. Con-
sequently, we believe that both the model and the re-
pellent demonstrate deserve serious consideration as
tools in the war against vector-borne disease.
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